Companies making headlines in the robotic surgery space over the past year include:Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …
This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic.
Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses.
We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail.
First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision.
Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal.
And, of course, Chris …
Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck.
In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices.
Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical, says new medtech tools must be connected to provide maximum benefit.
“If you’re making a device, you have to understand and build into it how it will be connected for that episode of care as as well as how it fits into the continuum of care,” Huennekens said in an interview with the DeviceTalks Weekly Podcast. “It just has to be part of the way you’re thinking.”
Verb Surgical, of course, is now part of Johnson & Johnson’s surgical robot product line, Ottava, which the company unveiled last year.
In a separate interview on the podcast, Mark Toland, the former CEO o…
Mark Toland, the former CEO of Corindus Vascular Robotics, believes the next big opportunity for surgical robotics is actually very small.
Toland, who sold the telesurgery robotics company to Siemens in 2019 for $1.1 billion, is now the CEO of Medical Microinstruments S.p.A. (MMI), an Italian company that has developed a surgical robotic system capable of performing microsurgery on capillaries, small vessels and other parts of the body existing robots – and maybe even surgeons – can’t reach.
“You see robotics companies that are trying to be the next Intuitive surgical or go after the laparoscopic surgery play,” Toland says. The objective “of this company is, `I want to create a field that doesn’t even exist today.’”
Founded in 2015 near Pisa, MMI in 2019 secured a CE-Mark for its Symani Surgical System to be used in open microsurgical procedures. The system already has been used in four surgical procedures in Florence, Italy including t…